Table 3. Different immunohistochemical expression levels of SSTR2A, 5 and CXCR4 (number of positive cases/total cases).
(IRS > 2 and < 5 points) | G1 | G2 | G3 | |
G3a | G3b | |||
CXCR4 | 11/31 (35.5%) | 26/47 (55.3%) | 13/18 (72.2%) | 19/22 (86.4%) |
SSTR2A | 31/31 (100%) | 45/47 (95.7%) | 12/17 (70.6%) | 14/22 (63.6%) |
SSTR5 | 20/31 (64.5%) | 42/47 (89.4%) | 13/17 (76.5%) | 20/22 (90.9%) |
(IRS ≥ 5 and ≤ 8) | G1 | G2 | G3 | |
G3a | G3b | |||
CXCR4 | 7/31 (20.0%) | 10/47 (21.3%) | 5/18 (27.8%) | 15/22 (68.2%) |
SSTR2A | 28/31 (90.3%) | 43/47 (91.5%) | 7/17 (41.2%) | 10/22 (45.5%) |
SSTR5 | 10/31 (32.3%) | 25/47 (53.2%) | 10/17 (58.8%) | 11/22 (50.0%) |
(IRS > 8) | G1 | G2 | G3 | |
G3a | G3b | |||
CXCR4 | 0/31 (0.0%) | 2/47 (4.3%) | 1/18 (5.6%) | 11/22 (50.0%) |
SSTR2A | 22/31 (71.0%) | 30/47 (63.8%) | 3/17 (17.6%) | 6/22 (27.3%) |
SSTR5 | 2/31 (6.5%) | 4/47 (8.5%) | 3/17 (17.6%) | 2/22 (9.1%) |